Evidence map›Paper›PMID 40170544›Full record

ArticlePhysiological reports2025

Plasma proteomic profiles correlate with organ dysfunction in COVID-19 ARDS.

Moemen Eltobgy, Brett Klamer, Daniela Farkas, James D Londino, Joshua A Englert, Jeffrey C Horowitz, Rama K Mallampalli, Guy Brock, Joseph S Bednash

Abstract read
In one paragraph

Article in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Moemen EltobgyDepartment of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.
Brett KlamerDepartment of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA.
Daniela FarkasDepartment of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.
James D LondinoDepartment of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.
Joshua A EnglertDepartment of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.
Jeffrey C HorowitzDepartment of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.
Rama K MallampalliDepartment of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.
Guy BrockDepartment of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA.
Joseph S BednashDepartment of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0003-3576-4388

Funding

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUM1TR004548 · NCATS · OHIO STATE UNIVERSITY · PI CYNTHIA A GERHARDT, JULIE A. JOHNSON · 2023 to 2026
$22.0M
Regulation of Cardiolin Byosynthesis in Epithelial InjuryP01HL114453 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCVERRY, BRYAN J · 2014 to 2023
$21.3M
TNF-alpha Control of a Surfactant Enzyme in Lung InjuryR01HL081784 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2006 to 2024
$5.4M
F box-Induced Acute Lung Injury and ParkinR01HL096376 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2010 to 2025
$5.1M
Sepsis-Associated Immune Suppression and F-box ProteinsR01HL097376 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2009 to 2025
$5.1M
Dissecting the molecular mechanisms of lung injury during mechanical ventilationR01HL142767 · NHLBI · OHIO STATE UNIVERSITY · PI ENGLERT, JOSHUA A · 2021 to 2025
$2.8M
X-Linked Inhibitor of Apoptosis in Fibroblast Phenotypes and Lung FibrosisR01HL141195 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOROWITZ, JEFFREY C · 2018 to 2021
$2.3M
Hypoxia-induced aberrant lactate generation and shuttling serves as a direct signal to promote pro-fibrotic fibroblast phenotypesR01HL171164 · NHLBI · OHIO STATE UNIVERSITY · PI Jeffrey C Horowitz, Richard S. Nho · 2025 to 2026
$1.5M
Transfer RNAs as novel mediators in acute lung injuryK08HL169725 · NHLBI · OHIO STATE UNIVERSITY · PI Joseph Stanley Bednash · 2024 to 2026
$491k
HHS | NIH | National Center for Advancing Translational Sciences (NCATS) UM1TR004548HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) K08HL169725HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) P01HL114453HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL081784HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL096376HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL097376HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL141195HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL142767NHLBI NIH HHS K08 HL169725NHLBI NIH HHS R01 HL171164OSU | College of Medicine Office of Research, Ohio State University (COMOR)
6 · The paper itself

Abstract

Severe COVID-19 is often complicated by hypoxemic respiratory failure and acute respiratory distress syndrome (ARDS). Mechanisms governing lung injury and repair in ARDS remain poorly understood. We hypothesized that plasma proteomics may uncover protein biomarkers correlated with COVID-19 ARDS severity. We analyzed the plasma proteome from 32 patients with ARDS and COVID-19 using an aptamer-based platform of 7289 proteins, and correlated protein measurements with sequential organ failure assessment (SOFA) scores at days 1 and 7 of ICU admission. We identified 184 differentially abundant proteins correlated with SOFA at day 1 and 46 proteins at day 7. In a longitudinal analysis, we correlated dynamic changes in protein abundance and SOFA between days 1 and 7 and identified 40 significant proteins. Pathway analysis of significant proteins identified increased ephrin signaling and acute phase response signaling correlated with increased SOFA scores between days 1 and 7, while pathways related to pulmonary fibrosis signaling and wound healing had a negative correlation. These findings suggest that persistent inflammation may drive disease severity, while repair processes correlate with improvements in organ dysfunction. This approach is generalizable to future ARDS cohorts for identification of biomarkers and disease mechanisms as we strive towards targeted therapies in ARDS.

Indexed as

Blood ProteinsCOVID-19Multiple Organ FailureProteomeRespiratory Distress SyndromeAdultAgedBiomarkersFemaleHumansLongitudinal StudiesMaleMiddle AgedOrgan Dysfunction ScoresProteomicsSARS-CoV-2BiomarkersBlood ProteinsProteomeacute respiratory distress syndromeCOVID‐19proteomic analysisSARS‐CoV‐2

Identifiers

PMID40170544
PMCPMC11962209

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.